Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Chin, 2006, Genomic and transcriptional aberrations linked to breast cancer pathophysiologies, Cancer Cell, 10, 529, 10.1016/j.ccr.2006.10.009
Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 98, 10869, 10.1073/pnas.191367098
Campbell, 2010, The patterns and dynamics of genomic instability in metastatic pancreatic cancer, Nature, 467, 1109, 10.1038/nature09460
Stephens, 2009, Complex landscapes of somatic rearrangement in human breast cancer genomes, Nature, 462, 1005, 10.1038/nature08645
Pleasance, 2010, A small-cell lung cancer genome with complex signatures of tobacco exposure, Nature, 463, 184, 10.1038/nature08629
Pleasance, 2010, A comprehensive catalogue of somatic mutations from a human cancer genome, Nature, 463, 191, 10.1038/nature08658
Ashworth, 2008, A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair, J Clin Oncol, 26, 3785, 10.1200/JCO.2008.16.0812
Farmer, 2005, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, 434, 917, 10.1038/nature03445
Ashworth, 2011, Genetic interactions in cancer progression and treatment, Cell, 145, 30, 10.1016/j.cell.2011.03.020
Moffat, 2006, Building mammalian signalling pathways with RNAi screens, Nat Rev Mol Cell Biol, 7, 177, 10.1038/nrm1860
Sigoillot, 2011, Vigilance and validation: keys to success in RNAi screening, ACS Chem Biol, 6, 47, 10.1021/cb100358f
Luo, 2008, Highly parallel identification of essential genes in cancer cells, Proc Natl Acad Sci U S A, 105, 20380, 10.1073/pnas.0810485105
Schlabach, 2008, Cancer proliferation gene discovery through functional genomics, Science, 319, 620, 10.1126/science.1149200
Silva, 2008, Profiling essential genes in human mammary cells by multiplex RNAi screening, Science, 319, 617, 10.1126/science.1149185
Luo, 2009, A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene, Cell, 137, 835, 10.1016/j.cell.2009.05.006
Bivona, 2011, FAS and NF-kappaB signalling modulate dependence of lung cancers on mutant EGFR, Nature, 471, 523, 10.1038/nature09870
Mendes-Pereira, 2011, Breast Cancer Special Feature: genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen, Proc Natl Acad Sci U S A
Cheung, 2011, Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer, Proc Natl Acad Sci U S A, 108, 12372, 10.1073/pnas.1109363108
Hudson, 2010, International network of cancer genome projects, Nature, 464, 993, 10.1038/nature08987
Moffat, 2006, A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen, Cell, 124, 1283, 10.1016/j.cell.2006.01.040
Root, 2001, High-affinity actin-binding nebulin fragments influence the actoS1 complex, Biochemistry, 40, 1171, 10.1021/bi0015010
Ketela, 2011, A comprehensive platform for highly multiplexed mammalian functional genetic screens, BMC Genomics, 12, 213, 10.1186/1471-2164-12-213
Konig, 2007, A probability-based approach for the analysis of large-scale RNAi screens, Nature Methods, 4, 847, 10.1038/nmeth1089
O'Brien, 2005, Inparanoid: a comprehensive database of eukaryotic orthologs, Nucleic Acids Res, 33, D476, 10.1093/nar/gki107
Su, 2004, A gene atlas of the mouse and human protein-encoding transcriptomes, Proc Natl Acad Sci U S A, 101, 6062, 10.1073/pnas.0400782101
Moffat, 2007, Off-target effects associated with long dsRNAs in Drosophila RNAi screens, Trends Pharmacol Sci, 28, 149, 10.1016/j.tips.2007.02.009
Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, 102, 15545, 10.1073/pnas.0506580102
Zhang, 2011, Mutant K-Ras increases GSK-3β gene expression via an ETS-p300 transcriptional complex in pancreatic cancer, Oncogene, 30, 3705, 10.1038/onc.2011.90
Fuchs, 2010, Clustering phenotype populations by genome-wide RNAi and multiparametric imaging, Mol Syst Biol, 6, 370, 10.1038/msb.2010.25
Katsumoto, 2008, Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis, Cancer Sci, 99, 1523, 10.1111/j.1349-7006.2008.00865.x
Hasegawa, 2004, SSX expression in gynecological cancers and antibody response in patients, Cancer Immun, 4, 16
Gure, 2005, Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer, Clin Cancer Res, 11, 8055, 10.1158/1078-0432.CCR-05-1203
Shi, 2010, Traf6 and A20 differentially regulate TLR4-induced autophagy by affecting the ubiquitination of Beclin 1, Autophagy, 6, 986, 10.4161/auto.6.7.13288
Bachmann, 2005, The serine/threonine kinase Pim-1, Int J Biochem Cell Biol, 37, 726, 10.1016/j.biocel.2004.11.005
Lamason, 2010, Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain, Biochemistry, 49, 8240, 10.1021/bi101052d
Wood, 2007, The genomic landscapes of human breast and colorectal cancers, Science, 318, 1108, 10.1126/science.1145720
Ormandy, 2003, Cyclin D1, EMS1 and 11q13 amplification in breast cancer, Breast Cancer Res Treat, 78, 323, 10.1023/A:1023033708204
Zafrakas, 2008, Enhancer of the rudimentary gene homologue (ERH) expression pattern in sporadic human breast cancer and normal breast tissue, BMC Cancer, 8, 145, 10.1186/1471-2407-8-145
Serrero, 2003, Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis, Biochem Biophys Res Commun, 308, 409, 10.1016/S0006-291X(03)01452-9
Lim, 2010, Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology, Carcinogenesis, 31, 512, 10.1093/carcin/bgp324
Lu, 2008, Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity, Endocrinology, 149, 4809, 10.1210/en.2008-0035
Kiyotani, 2010, Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients, J Clin Oncol, 28, 1287, 10.1200/JCO.2009.25.7246
Hurtado, 2011, FOXA1 is a key determinant of estrogen receptor function and endocrine response, Nat Genet, 43, 27, 10.1038/ng.730
Lupien, 2008, FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription, Cell, 132, 958, 10.1016/j.cell.2008.01.018
Badve, 2007, FOXA1 expression in breast cancer—correlation with luminal subtype A and survival, Clin Cancer Res, 13, 4415, 10.1158/1078-0432.CCR-07-0122
van de Vijver, 2002, A gene-expression signature as a predictor of survival in breast cancer, N Engl J Med, 347, 1999, 10.1056/NEJMoa021967
Prat, 2010, Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, Breast Cancer Res, 12, R68, 10.1186/bcr2635
Kosco, 2008, SKAP55 modulates T cell antigen receptor-induced activation of the Ras-Erk-AP1 pathway by binding RasGRP1, Mol Immunol, 45, 510, 10.1016/j.molimm.2007.05.024
Kobayashi, 2006, Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions, Mol Cell Biol, 26, 898, 10.1128/MCB.26.3.898-911.2006
Vogel, 2001, Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development, Mol Cell Biol, 21, 2906, 10.1128/MCB.21.8.2906-2917.2001
Vogel, 2006, Sensing extracellular matrix: an update on discoidin domain receptor function, Cell Signal, 18, 1108, 10.1016/j.cellsig.2006.02.012
Kim, 2011, DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation, J Biol Chem, 286, 17672, 10.1074/jbc.M111.236612
Hammerman, 2011, Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer, Cancer Discovery, 1, 78, 10.1158/2159-8274.CD-11-0005
Barbie, 2009, Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, 462, 108, 10.1038/nature08460
Scholl, 2009, Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells, Cell, 137, 821, 10.1016/j.cell.2009.03.017
Singh, 2009, Oncogenic K-ras “addiction” and synthetic lethality, Cell Cycle, 8, 2676, 10.4161/cc.8.17.9336
Kao, 2009, Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery, PLoS One, 4, e6146, 10.1371/journal.pone.0006146
Neve, 2006, A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, 10, 515, 10.1016/j.ccr.2006.10.008
Collisson, 2011, Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy, Nat Med, 17, 500, 10.1038/nm.2344
Lehmann, 2009, A novel S3S-TAP-tag for the isolation of T-cell interaction partners of adhesion and degranulation promoting adaptor protein, Proteomics, 9, 5288, 10.1002/pmic.200900294
Wang, 2007, Functional defects of SKAP-55-deficient T cells identify a regulatory role for the adaptor in LFA-1 adhesion, Mol Cell Biol, 27, 6863, 10.1128/MCB.00556-07
Goode, 2010, A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24, Nat Genet, 42, 874, 10.1038/ng.668
Huang, 2011 6, Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy
D'Angelo, 2004, Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis, Cancer Cell, 5, 137, 10.1016/S1535-6108(04)00021-2
Zollo, 2005, Overexpression of h-prune in breast cancer is correlated with advanced disease status, Clin Cancer Res, 11, 199, 10.1158/1078-0432.199.11.1
Forus, 2001, Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas—a possible mechanism for altering the nm23-H1 activity, Oncogene, 20, 6881, 10.1038/sj.onc.1204874
Pittman, 2010, Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H, PLoS Genet, 6, e1001126, 10.1371/journal.pgen.1001126
Cappuzzo, 2009, MYC and EIF3H coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib, J Thorac Oncol, 4, 472, 10.1097/JTO.0b013e31819a5767
Saramaki, 2001, Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer, Am J Pathol, 159, 2089, 10.1016/S0002-9440(10)63060-X
Savinainen, 2004, Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer, Br J Cancer, 90, 1041, 10.1038/sj.bjc.6601648
Okamoto, 2003, PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas, Hepatology, 38, 1242, 10.1053/jhep.2003.50457
Lanzetti, 2000, The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5, Nature, 408, 374, 10.1038/35042605
Chen, 2010, Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis, Cancer Res, 70, 9979, 10.1158/0008-5472.CAN-10-2394
Welsch, 2007, Eps8 is increased in pancreatic cancer and required for dynamic actin-based cell protrusions and intercellular cytoskeletal organization, Cancer Lett, 255, 205, 10.1016/j.canlet.2007.04.008
Yap, 2009, Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation, Oncogene, 28, 2524, 10.1038/onc.2009.105
Cooper, 2002, The role of alpha(v)beta(3) in prostate cancer progression, Neoplasia, 4, 191, 10.1038/sj.neo.7900224
Amsterdam, 2004, Identification of 315 genes essential for early zebrafish development, Proc Natl Acad Sci U S A, 101, 12792, 10.1073/pnas.0403929101